You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

glucocorticoid-induced tumor necrosis factor receptor (GITR)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Gout Trial in Nanchang (rhTNFR-Fc, Triamcinolone Acetonide)

Not yet recruiting
  • Acute Gout
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Jun 28, 2023

Rheumatoid Arthritis Trial in Copenhagen (Exercise, No exercise)

Recruiting
  • Rheumatoid Arthritis
  • Exercise
  • No exercise
  • Copenhagen, Denmark
    Rigshospitalet
Feb 3, 2022

Chemo-induced Thrombocytopenia (CIT) Trial in Chengdu (Recombinant Human Tumor Necrosis Factor Receptor II -Fc-TPO Mimetic

Recruiting
  • Chemotherapy-induced Thrombocytopenia (CIT)
  • Recombinant Human Tumor Necrosis Factor Receptor II -Fc-TPO Mimetic Peptide Fusion Protein
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Jun 23, 2022

Gulf War Illness Trial in Davie, Miami (Etanercept, Mifepristone)

Recruiting
  • Gulf War Illness
  • Davie, Florida
  • +1 more
May 9, 2022

HIV Trial in Honolulu, New York, Cleveland (Tumor Necrosis Factor soluble receptor-immunoadhesin complex)

Completed
  • HIV Infections
  • Tumor Necrosis Factor soluble receptor-immunoadhesin complex
  • Honolulu, Hawaii
  • +2 more
Oct 28, 2021

Squamous Cell Carcinoma of Head and Neck Trial in Spain, United States (REGN6569, Cemiplimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Los Angeles, California
  • +9 more
Jun 20, 2022

Psoriasis Trial in Irvine, Winston-Salem, Seattle (Etanercept, Placebo injections)

Completed
Has Results
  • Psoriasis
  • Etanercept
  • Placebo injections
  • Irvine, California
  • +2 more
Jun 10, 2021

Long-term Treatment With YISAIPU for Fujian RA Patients

Recruiting
  • Rheumatoid Arthritis
  • YISAIPU® ( An etanercept biosimilar)
  • csDMARDs
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
Jun 15, 2022

Advanced Breast Cancer Trial in Poland, Turkey (Plasma soluble TNF receptor pulldown, Plasma soluble TNF receptor pulldown +

Recruiting
  • Advanced Breast Cancer
  • Plasma soluble TNF receptor pulldown
  • +2 more
  • Kraków, Małopolskie, Poland
  • +4 more
Mar 9, 2022

Non Small Cell Lung Cancer Trial in Istanbul (LW-02 device immunopheresis combined with atezolizumab, LW-02 device

Recruiting
  • Non Small Cell Lung Cancer
  • LW-02 device immunopheresis combined with atezolizumab
  • +2 more
  • Istanbul, Kucukcekmece, Turkey
  • +2 more
Mar 6, 2022

Warts Trial in Zagazig (Candida antigen)

Completed
  • Warts
  • Candida antigen
  • Zagazig, Sharqia, Egypt
    Zagazig University Faculty of Medicine
May 24, 2020

Arthritis, Rheumatoid Trial in Belgium (Etanercept 50 MG/ML, Leflunomide 10 milligram (MG))

Completed
  • Arthritis, Rheumatoid
  • Etanercept 50 MG/ML
  • Leflunomide 10 milligram (MG)
  • Bonheiden, Antwerpen, Belgium
  • +18 more
Jul 4, 2022

Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)

Active, not recruiting
Has Results
  • Melanoma
  • FDG PET/CT scan
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Jan 10, 2023

Advanced Solid Tumor, Cutaneous T Cell Lymphoma Trial in Guanzhou (SIM1811-03)

Recruiting
  • Advanced Solid Tumor
  • Cutaneous T Cell Lymphoma
  • Guanzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Mar 10, 2023

Stress Response Trial (tDCS actif, tDCS Sham)

Not yet recruiting
  • Stress Response
  • tDCS actif
  • tDCS Sham
  • (no location specified)
Apr 20, 2023

Pneumonia, Idiopathic Pneumonia Syndrome Trial in United States (Etanercept, Placebo plus corticosteroid)

Completed
Has Results
  • Pneumonia
  • Idiopathic Pneumonia Syndrome
  • Gainesville, Florida
  • +11 more
Oct 21, 2021

Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) Trial in United States (SIM1811-03)

Recruiting
  • Advanced Solid Tumor
  • Cutaneous T-cell Lymphoma (CTCL)
  • Detroit, Michigan
  • +5 more
Oct 6, 2022

Inflammatory and Anti-Inflammatory Gene Expressions in Liver

Active, not recruiting
  • Liver Transplant; Complications
  • +3 more
  • Molecular Immunology , gene expressions
  • Malatya, Turkey
    İnönü University
May 2, 2023

Osteosarcoma Trial (Surufatinib plus chemo, Chemotherapy)

Not yet recruiting
  • Osteosarcoma
  • (no location specified)
Jun 29, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

Periimplant Soft Tissue Phenotype on Marginal Bone Loss

Completed
  • Alveolar Bone Loss
  • +2 more
  • Nuclear Factor-Kappa B Ligand (RANKL) analysis
  • +4 more
  • Konya, Turkey
    Necmettin Erbakan University, dentistry Faculty
Jan 24, 2023

Advanced Malignant Solid Tumor, Metastatic Carcinoma in the Liver, Metastatic Carcinoma in the Lung Trial in Houston (drug,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Anti-GITR Agonistic Monoclonal Antibody BMS-986156
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2021

Depression Trial in Atlanta (Infliximab, Placebo)

Active, not recruiting
  • Depression
  • Atlanta, Georgia
    Emory University
Jan 23, 2023

Advanced Malignancies, Metastatic Cancer Trial in Los Angeles, Hackensack (INCAGN01876, Epacadostat, Pembrolizumab)

Terminated
Has Results
  • Advanced Malignancies
  • Metastatic Cancer
  • Los Angeles, California
  • +1 more
Jul 1, 2021

Chemo, Colorectal Cancer, Intestinal Mucositis Trial (Losartan 50mg Tab)

Not yet recruiting
  • Chemotherapy
  • +3 more
  • Losartan 50mg Tab
  • (no location specified)
May 13, 2023